Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Complex ANDAs: Early Meetings With FDA Can Generate Bonus Communication

Executive Summary

By conducting a product development or pre-submission meeting, sponsors can receive a mid-review cycle meeting for a complex product ANDA.

Advertisement

Related Content

Competitive Generic Therapies Get Help With Development, But Not Goal Date
ANDA Pre-Submission Meetings A 'Challenge' To Integrate Into Development Timelines
ANDA Pre-Submission Meetings A 'Challenge' To Integrate Into Development Timelines
Opioid, NME, And Generic Drugs Changes Plotted In US FDA's 2018 Policy Roadmap
FDA's Off-Patent, Off-Exclusivity List Draws Few Takers Early On
Gottlieb Places Drug Pricing Out Front In First Speech To US FDA Staff
Generic Drug First-Cycle Approval Rates Lagging Under GDUFA I
Complex ANDAs To Be Allowed Pre-Submission Product Meetings
How To Get A Meeting With FDA: Guidance Describes Formal Meetings For Biosimilars
Buying Time: Industry Sacrifices Early To Gain Later With PDUFA V Review Model

Topics

Advertisement
UsernamePublicRestriction

Register

PS121683

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel